| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/11/1992 | WO1992009563A1 Improved matrix metalloprotease inhibitors |
| 06/11/1992 | WO1992009306A1 Utilization of immunoglobulines administered locally in the treatment of epithelial infections |
| 06/11/1992 | WO1992009305A1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 06/11/1992 | WO1992009304A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 06/11/1992 | WO1992009303A1 Albumin preparation and preservation thereof |
| 06/11/1992 | WO1992009301A1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
| 06/11/1992 | WO1992009300A1 Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures |
| 06/11/1992 | WO1992009298A1 The delay, prevention and/or reversal of cell senescence |
| 06/11/1992 | WO1992009297A1 Hiv protease inhibitors |
| 06/11/1992 | WO1992009296A1 A peptide which regulates weight gain in mammals |
| 06/11/1992 | WO1992009293A1 Inhibition of cell adhesion protein-carbohydrate interactions |
| 06/11/1992 | WO1992009282A1 Treatment for tissue ulceration |
| 06/11/1992 | WO1992009277A1 Nutrient supply |
| 06/11/1992 | WO1992009200A1 Novel polypeptides for promoting cell attachment |
| 06/11/1992 | WO1992007254A3 Use of disulphide bidged substances |
| 06/11/1992 | DE4038947A1 Dithiolano- und dithianoglycin-haltige renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Dithiolano- and dithianoglycin-containing peptide renininhibitorische, process for their production and their use in medicinal products |
| 06/11/1992 | DE4038921A1 Renininhibitorische peptide vom cyclohexylstatin-typ, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Renininhibitorische peptide from cyclohexylstatin-type, process for their production and their use in medicinal products |
| 06/11/1992 | DE4038692A1 Agent for treating eye disorders esp. grey star - consists of demineralised sterilised water contg. urea and/or other substances, such as glycol, animal protein, plant extracts etc. |
| 06/11/1992 | CA2097617A1 Inhibition of cell adhesion protein-carbohydrate interactions |
| 06/11/1992 | CA2096225A1 Matrix metalloprotease inhibitors |
| 06/11/1992 | CA2074802A1 Interferons derived mutants of type i, their production process and applications |
| 06/11/1992 | CA2073860A1 Analytical tracers for cancer, particularly malignant breast cancer |
| 06/11/1992 | CA2057269A1 Process for the enzymatic preparation of grf(1-44)nh2 |
| 06/10/1992 | EP0489711A2 Method for producing human growth hormone |
| 06/10/1992 | EP0489579A1 Peptidyl derivatives |
| 06/10/1992 | EP0489577A1 Peptidyl derivatives |
| 06/10/1992 | EP0489220A1 Cytotoxic N,N'-bis (succinyl-peptide-) derivatives of 1,4-bis (aminoalkyl)-5,8-dihydroxyanthraquinones and antibody conjugates thereof |
| 06/10/1992 | EP0489217A1 Calcitonin compositions for intranasal administration |
| 06/10/1992 | EP0489201A1 Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant DNA and transformed microorganisms |
| 06/10/1992 | EP0489180A1 Anticoagulant polypeptides |
| 06/10/1992 | EP0489113A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
| 06/10/1992 | EP0489062A1 Bone-specific protein |
| 06/10/1992 | EP0489058A1 Cystic fibrosis gene |
| 06/10/1992 | EP0174367B1 Hosts and methods for producing recombinant products in high yields |
| 06/09/1992 | US5120859 Chimeric amino acid analogues |
| 06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
| 06/09/1992 | US5120833 Method of producing grafts |
| 06/09/1992 | US5120832 Having specified dna sequence and free from other proteins; viricides, antitumor agents |
| 06/09/1992 | US5120831 Metal-peptide compositions |
| 06/09/1992 | US5120830 Anticoagulant |
| 06/09/1992 | US5120740 Targeting antitumor drugs to kidneys |
| 06/09/1992 | US5120715 Method for purifying fibroblast growth factor protein |
| 06/09/1992 | US5120714 Method for the diagnosis and treatment of human granulomatous inflammatory disease |
| 06/09/1992 | US5120713 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
| 06/09/1992 | US5120712 Insulinotropic hormone |
| 06/09/1992 | US5120711 Synergistically active veterinary compositions and process for preparing same |
| 06/09/1992 | US5120710 Oral lipid medicinal composition |
| 06/09/1992 | US5120642 Medical diagnosis |
| 06/09/1992 | US5120539 Diarrhea therapy for infants |
| 06/09/1992 | US5120537 Factor X or fragment thereof having little or no serine esterase activity, which is capable of binding with factor V in the blood of a mammal, and a carrier |
| 06/09/1992 | US5120535 Synergistic mixture with interferons |
| 06/09/1992 | US5120534 Administering at least one polypeptide from interleukin and derivatives |
| 06/09/1992 | CA1303294C .alpha.-HYDROXY THIOETHERS |
| 06/09/1992 | CA1302928C Purification procedure of tpa from crude preparations |
| 06/09/1992 | CA1302919C Histamine derivatives, immunogen conjugates and antibodies raised thereto |
| 06/09/1992 | CA1302887C Combination of acyclovir or a derivative thereof and bacitracin |
| 06/09/1992 | CA1302884C Pasteurization of immunoglobulin solutions |
| 06/09/1992 | CA1302882C Vaccines and immunoglobulin g-containing preparations active against pseudomonas aeruginosa |
| 06/09/1992 | CA1302880C Agents for the treatment of arthroses |
| 06/09/1992 | CA1302879C Composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine |
| 06/09/1992 | CA1302878C Agent for the regulation of the appetite or a sleeping agent |
| 06/08/1992 | WO1992010575A1 Bifunctional inhibitors of thrombin and platelet activation |
| 06/08/1992 | WO1992010572A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
| 06/08/1992 | CA2097509A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
| 06/08/1992 | CA2096545A1 Bifunctional inhibitors of thrombin and platelet activation |
| 06/08/1992 | CA2057157A1 Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections |
| 06/07/1992 | WO1992010205A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
| 06/07/1992 | CA2097825A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
| 06/06/1992 | WO1992010516A1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them |
| 06/06/1992 | CA2095725A1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics and a process for preparing them |
| 06/06/1992 | CA2038845A1 An agent for reducing the growth of or removing the hair on the human body |
| 06/05/1992 | WO1992010562A1 Ganoderma lucidium iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity |
| 06/05/1992 | WO1992010209A1 Bifunctional antibodies and method of preparing same |
| 06/05/1992 | WO1992010202A1 Proteoglycan(g 009) effective in enhancing antitumor immunity |
| 06/05/1992 | WO1992010199A1 Therapeutic and diagnostic applications of fetal fibronectin |
| 06/05/1992 | CA2097060A1 Bifunctional antibodies and method of preparing same |
| 06/05/1992 | CA2075300A1 Therapeutic and diagnostic applications of fetal fibronectin |
| 06/04/1992 | WO1992009616A1 Enhancement of musculature in animals |
| 06/04/1992 | WO1992009613A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
| 06/04/1992 | WO1992009565A1 Peptidyl derivatives |
| 06/04/1992 | WO1992009564A1 Peptidyl derivatives |
| 06/04/1992 | DE4038189A1 Epididymis-specific DNA sequences |
| 06/04/1992 | DE4037809A1 Staphylococcal neutral phosphatase and 70 KD protein - isolated by immuno:affinity purificn., ion exchange chromatography or affinity chromatography and used to stimulate lymphocytes and bind immunoglobulins |
| 06/04/1992 | CA2097590A1 Enhancement of musculature in animals |
| 06/04/1992 | CA2097416A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
| 06/04/1992 | CA2073513A1 Peptidyl derivatives |
| 06/04/1992 | CA2073510A1 Peptidyl derivatives |
| 06/03/1992 | EP0488979A1 Novel inhibitory peptides |
| 06/03/1992 | EP0488900A1 Protein with cytokine activity, recombinant DNA, expression vector and hosts for obtaining it |
| 06/03/1992 | EP0488718A2 Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine |
| 06/03/1992 | EP0488589A1 Process for producing kappa-casein glycomacropeptides |
| 06/03/1992 | EP0488479A1 DNA sequences, recombinant DNA molecules and processes for producing swine growth hormone-like polypeptides |
| 06/03/1992 | EP0488317A2 Thrombin-binding substance and process for preparing the same |
| 06/03/1992 | EP0488258A2 Propenamide derivatives, polymers, copolymers and use thereof |
| 06/03/1992 | EP0488224A2 Fermentationproduct of a Verticimonosporium strain and feed additivs containing a linear peptide |
| 06/03/1992 | EP0488196A2 HST-2, a member of the heparin binding growth factor family |
| 06/03/1992 | EP0488061A2 The MAC-1 binding site of ICAM-1 |
| 06/03/1992 | EP0488059A2 Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria |
| 06/03/1992 | EP0488041A2 A pharmaceutical composition for cytomegalovirus infection |
| 06/03/1992 | EP0487909A2 Novel muramyldipeptide derivatives and influenza vaccine comprising the derivatives |